Ga. Comp. R. & Regs. R. 480-34-.08 - Lidocaine

(1) This rule was adopted to protect the health, safety, and welfare of the public. Lidocaine topical, 40 mg/gm. or less (4.0%) is deleted from Official Code of Georgia Annotated (O.C.G.A.) § 16-13-71(b)(520).

(2) This rule is based on the following findings of the Board:

(a) that lidocaine topical, 40 mg/gm. or less (4.0%) does not have a high potential for abuse;

(b) that the Board has considered the scientific evidence of its pharmacological effects, the state of current scientific knowledge regarding the drug, the history and current pattern of abuse, the scope, duration, and significance of abuse, the potential of the drug to produce psychic or physiological dependence liability; and

(c) that the drug is no longer included as a prescription drug under the Federal Food, Drug, and Cosmetic Act, 21 U.S.C. Section 301, et. seq., as amended.

Notes

Ga. Comp. R. & Regs. R. 480-34-.08

§§ 16-13-71, 26-4-27, 50-13-4.

Original Rule filed as Emergency Rule 480-34-0.24-.08 entitled "Lidocaine" on May 14, 2015; effective May 13, 2015, the date of adoption, to remain in effect for a period of 120 days or until the effective date of a permanent Rule covering the same subject matter superseding this Emergency Rule is adopted, as specified by the Agency. Adopted: Permanent Rule of the same title. F. Sep. 18, 2015; eff. Oct. 8, 2015.